| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $766.6M | +2.8% |
| R&D Expense | $143.1M | +13.7% |
| SG&A Expense | $144.8M | -6.4% |
| Operating Income | $1.7M | -87.0% |
| Interest Expense | $34.2M | +44.8% |
| Pre-tax Income | -$23.2M | -128.3% |
| Income Tax | $9.6M | -36.3% |
| Net Income | -$32.8M | -30.0% |
| EPS (Basic) | -$0.08 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $757.2M | -19.5% |
| Accounts Receivable | $117.1M | -0.8% |
| Current Assets | $919.7M | -15.5% |
| Total Assets | $1.60B | -0.2% |
| Current Liabilities | $76.3M | -5.9% |
| Long-term Debt | $667.1M | -1.0% |
| Total Liabilities | $789.8M | +1.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $146.8M | -17.9% |
| Capital Expenditures | $4.0M | -13.2% |
| Investing Cash Flow | -$210.5M | -17.8% |
| Financing Cash Flow | -$120.2M | -293.8% |
| Free Cash Flow | $142.8M | -18.0% |
| -33.3% |
| EPS (Diluted) | -$0.08 | -33.3% |
| Stockholders' Equity |
| $814.8M |
| -2.0% |